Cas 936616-49-8,phenyl-[benzyloxy-L-alaninyl]-[((1R,3R,4R,7R)-3-(adenine-9-yl)-7-hydroxy-2,5-dioxabicyclo[2:2:1]heptane-1-yl)methyl] phosphate

936616-49-8

Post Buying Request

Basic information

Product Name: phenyl-[benzyloxy-L-alaninyl]-[((1R,3R,4R,7R)-3-(adenine-9-yl)-7-hydroxy-2,5-dioxabicyclo[2:2:1]heptane-1-yl)methyl] phosphate
Synonyms:
CAS NO:936616-49-8
Molecular Formula:
Molecular Weight: 596.536
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: phenyl-[benzyloxy-L-alaninyl]-[((1R,3R,4R,7R)-3-(adenine-9-yl)-7-hydroxy-2,5-dioxabicyclo[2:2:1]heptane-1-yl)methyl] phosphate(CAS DataBase Reference)
NIST Chemistry Reference: phenyl-[benzyloxy-L-alaninyl]-[((1R,3R,4R,7R)-3-(adenine-9-yl)-7-hydroxy-2,5-dioxabicyclo[2:2:1]heptane-1-yl)methyl] phosphate(936616-49-8)
EPA Substance Registry System: phenyl-[benzyloxy-L-alaninyl]-[((1R,3R,4R,7R)-3-(adenine-9-yl)-7-hydroxy-2,5-dioxabicyclo[2:2:1]heptane-1-yl)methyl] phosphate(936616-49-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 936616-49-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

936616-49-8 Suppliers

Recommended suppliers

936616-49-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 936616-49-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,6,1 and 6 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 936616-49:
(8*9)+(7*3)+(6*6)+(5*6)+(4*1)+(3*6)+(2*4)+(1*9)=198
198 % 10 = 8
So 936616-49-8 is a valid CAS Registry Number.

936616-49-8Upstream product

936616-49-8Downstream Products

936616-49-8Relevant academic research and scientific papers

LNA NUCLEOSIDE PHOSPHORAMIDATES

-

Page/Page column 10-11, (2012/04/10)

The invention provides for a compound of formula I for use in medicine: (Formula I).

Synthesis and biological evaluation of LNA phosphoramidates

Jensen, Jacob,Sjogren, Gitte,Hansen, Jens Bo,Rosenbohm, Christoph,Koch, Troels

, p. 37 - 42 (2008/09/18)

The synthesis of LNA phosphoramidates is presented. The LNA phosphoramidates were evaluated for their ability to inhibit cell proliferation of the human prostate cancer cell line 15PC3. A number of the LNA phosphoramidates showed cell proliferation inhibition determined by the MTS assay. Copyright Taylor & Francis Group, LLC.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 936616-49-8